Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.23.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Revenue        
Revenue
Other revenue 45 985
Total revenue 45 985
Operating expenses:        
Research and development, net of reimbursements 11,081 4,662 18,930 9,031
General and administrative 4,561 3,233 8,296 4,968
Total operating expenses 15,642 7,895 27,226 13,999
Loss from operations (15,642) (7,850) (27,226) (13,014)
Other income:        
Interest income - net 461 83 1,008 118
Total other income 461 83 1,008 118
Net loss $ (15,181) $ (7,767) $ (26,218) $ (12,896)
Net loss per common share – basic and diluted (in Dollars per share) $ (0.58) $ (0.33) $ (1.01) $ (0.56)
Weighted average common shares outstanding – basic and diluted (in Shares) 26,217,910 23,731,886 25,958,706 22,942,317